HTiP: High-Throughput Immunomodulator Phenotypic Screening Platform to Reveal IAP Antagonists as Anti-cancer Immune Enhancers. | |
Mo Xiulei; Tang Cong; Niu Qiankun; Ma Tingxuan; Du Yuhong; Fu Haian | |
刊名 | Cell chemical biology |
2019 | |
卷号 | 26页码:331-+ |
关键词 | inhibitor of apoptosis protein KRAS mutation IAP antagonist tumor and immune cell co-culture small-molecule immunomodulator IAP |
ISSN号 | 2451-9448 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/2826692 |
专题 | 西安交通大学 |
推荐引用方式 GB/T 7714 | Mo Xiulei,Tang Cong,Niu Qiankun,et al. HTiP: High-Throughput Immunomodulator Phenotypic Screening Platform to Reveal IAP Antagonists as Anti-cancer Immune Enhancers.[J]. Cell chemical biology,2019,26:331-+. |
APA | Mo Xiulei,Tang Cong,Niu Qiankun,Ma Tingxuan,Du Yuhong,&Fu Haian.(2019).HTiP: High-Throughput Immunomodulator Phenotypic Screening Platform to Reveal IAP Antagonists as Anti-cancer Immune Enhancers..Cell chemical biology,26,331-+. |
MLA | Mo Xiulei,et al."HTiP: High-Throughput Immunomodulator Phenotypic Screening Platform to Reveal IAP Antagonists as Anti-cancer Immune Enhancers.".Cell chemical biology 26(2019):331-+. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论